Myriad Genetics, INC.
Molecular diagnostic company.
Based in DC
AI Overview
With $590K in lobbying spend across 21 quarterly filings, Myriad Genetics, INC is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2019 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $20K |
| 2020 | $120K |
| 2021 | $120K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $90K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Myriad Genetics, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Medicare/Medicaid, Budget/Appropriations, Health Issues, Veterans
Issues related to regulation of pharmcogenomic tests. FY20 HHS Appropriations bill regarding CMS coverage policies for mental health genetic tests.
Medicare coverage policies for mental health genetic tests.
Draft legislation to regulate clinical labs under CLIA and FDA.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.